Jonas Koponen

Jonas Koponen

Cooley LLP

Contact
View Bio
RSS

Latest Posts › Antitrust Provisions

Share:

Stiff EU Antitrust Fine for ‘Misuse’ of Patent System Delaying Rival Pharma Entry

On October 31, 2024, the European Commission (EC) fined Teva 462.6 million euros (US$503 million) for abusing its dominant position to delay competition to Copaxone (glatiramer acetate), its blockbuster multiple sclerosis...more

11/21/2024  /  Antitrust Provisions , Antitrust Violations , Competition , EU , Fines , Intellectual Property Protection , Patents

A Rising EU Antitrust Enforcement Tide: ‘Exclusionary Disparagement’ of Pharma Rivals

On October 31, 2024, the European Commission (EC) fined Teva 462.6 million euros (US$503 million) for abusing its dominant position to delay competition to Copaxone (glatiramer acetate), its blockbuster multiple sclerosis...more

11/21/2024  /  Antitrust Provisions , Disparagement , EU , European Commission , Pharmaceutical Industry
2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide